C-abl tyrosine kinase inhibitory compound embodiments and methods of making and using the same
US-2025340521-A1 · Nov 6, 2025 · US
[b, e]- or [b, f]-condensed with six-membered rings
[b, e]- or [b, f]-condensed with six-membered rings · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07D243/38 |
| Official title | [b, e]- or [b, f]-condensed with six-membered rings |
| Display label | [b, e]- or [b, f]-condensed with six-membered rings |
| Total patents | 40 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is stable.
| Year | Patents |
|---|---|
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 6 |
| 2019 | 3 |
| 2020 | 6 |
| 2021 | 6 |
| 2022 | 2 |
| 2023 | 7 |
| 2024 | 3 |
| 2025 | 5 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
c-Abl tyrosine kinase inhibitory compound embodiments and methods of making and using the same
US-12435047-B2 · Oct 7, 2025 · US
Compound, preparation and use thereof in rubber blends and vehicle tires, as an anti-aging agent, antioxidant, antioxidant and/or coloring agent
US-2025250241-A1 · Aug 7, 2025 · US
Modulators of orphan nuclear receptors for NASH and other metabolic disorders
US-12318393-B2 · Jun 3, 2025 · US
Azabicyclo and diazepine derivatives
US-12247028-B2 · Mar 11, 2025 · US
Azabicyclo and diazepine derivatives
US-2024132497-A1 · Apr 25, 2024 · US
Azabicyclo and diazepine derivatives
US-11884666-B2 · Jan 30, 2024 · US
Hepatitis b core protein modulators
US-2024025890-A1 · Jan 25, 2024 · US
Hepatitis b core protein modulators
US-11814376-B2 · Nov 14, 2023 · US
C-abl tyrosine kinase inhibitory compound embodiments and methods of making and using the same
US-2023303501-A1 · Sep 28, 2023 · US
DREADD actuators
US-11739063-B2 · Aug 29, 2023 · US
C-Abl tyrosine kinase inhibitory compound embodiments and methods of making and using the same
US-11649218-B2 · May 16, 2023 · US
Inhibitors of EGFR and methods of use thereof
US-11584746-B2 · Feb 21, 2023 · US
Hepatitis b core protein modulators
US-2023044112-A1 · Feb 9, 2023 · US
Hepatitis b core protein allosteric modulators
US-2023019129-A1 · Jan 19, 2023 · US
Azabicyclo and diazepine derivatives
US-2022267328-A1 · Aug 25, 2022 · US
Azabicyclo and diazepine derivatives
US-11306090-B2 · Apr 19, 2022 · US
Azabicyclo and diazepine derivatives
US-2021179616-A1 · Jun 17, 2021 · US
C-abl tyrosine kinase inhibitory compound embodiments and methods of making and using the same
US-2021101872-A1 · Apr 8, 2021 · US
Hepatitis B core protein modulators
US-10968211-B2 · Apr 6, 2021 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07D243/38?
- CPC C07D243/38 is the Cooperative Patent Classification code for “[b, e]- or [b, f]-condensed with six-membered rings.”
- How many patents are filed under CPC C07D243/38 ([b, e]- or [b, f]-condensed with six-membered rings)?
- Our database includes 40 publications tagged with this CPC code.
- Is patent activity under CPC C07D243/38 growing?
- Publication counts under this code: 3 in 2024 vs 5 in 2025 (latest complete years).